Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Income-Before-Tax" stands at 350.87 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Daiichi Sankyo Co. Ltd.'s first quarter result of 105.44 Billion JPY for the item "Income Before Tax" represents an increase of 30.77 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Daiichi Sankyo Co. Ltd.'s first quarter result of 105.44 Billion JPY for the item "Income Before Tax" represents a decrease of -4.32 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Daiichi Sankyo Co. Ltd.'s first quarter result of 350.87 Billion JPY for the item "Income Before Tax" represents a decrease of -1.34 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 18.82 percent compared to the value the year prior.
The 1 year change in percent is 18.82.
The 3 year change in percent is 528.06.
The 5 year change in percent is 179.64.
The 10 year change in percent is 262.87.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Income Before Tax | 905,699,262,464.00 |
![]() | Johnson & Johnson - Income Before Tax | 486,508,953,600.00 |
![]() | AbbVie Inc - Income Before Tax | 399,570,305,024.00 |
![]() | Roche Holding AG - Income Before Tax | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Income Before Tax | 280,205,508,085.11 |